Literature DB >> 26227505

Hsp90 Activity Modulation by Plant Secondary Metabolites.

Fabrizio Dal Piaz1, Stefania Terracciano1, Nunziatina De Tommasi1, Alessandra Braca2.   

Abstract

Hsp90 is an evolutionarily conserved adenosine triphosphate-dependent molecular chaperone and is one of the most abundant proteins in the cells (1-3 %). Hsp90 is induced when a cell undergoes various types of environmental stresses such as heat, cold, or oxygen deprivation. It is involved in the turnover, trafficking, and activity of client proteins, including apoptotic factors, protein kinases, transcription factors, signaling proteins, and a number of oncoproteins. Most of the Hsp90 client proteins are involved in cell growth, differentiation, and survival, and include kinases, nuclear hormone receptors, transcription factors, and other proteins associated with almost all the hallmarks of cancer. Consistent with these diverse activities, genetic and biochemical studies have demonstrated the implication of Hsp90 in a range of diseases, including cancer, making this chaperone an interesting target for drug research.During the last few decades, plant secondary metabolites have been studied as a major source for lead compounds in drug discovery. Recently, several plant-derived small molecules have been discovered exhibiting inhibitory activity towards Hsp90, such as epigallocatechin gallate, gedunin, lentiginosine, celastrol, and deguelin. In this work, an overview of plant secondary metabolites interfering with Hsp90 activities is provided. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26227505     DOI: 10.1055/s-0035-1546251

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  6 in total

Review 1.  Anticancer Inhibitors of Hsp90 Function: Beyond the Usual Suspects.

Authors:  Gaurav Garg; Anuj Khandelwal; Brian S J Blagg
Journal:  Adv Cancer Res       Date:  2016-02-10       Impact factor: 6.242

2.  Discovery of new molecular entities able to strongly interfere with Hsp90 C-terminal domain.

Authors:  Stefania Terracciano; Alessandra Russo; Maria G Chini; Maria C Vaccaro; Marianna Potenza; Antonio Vassallo; Raffaele Riccio; Giuseppe Bifulco; Ines Bruno
Journal:  Sci Rep       Date:  2018-01-26       Impact factor: 4.379

3.  The expression level of CSDAP1 in lung cancer and its clinical significance.

Authors:  Tongbai Xu; Dongsheng Li; Yuan He; Fuliang Zhang; Man Qiao; Yanhua Chen
Journal:  Oncol Lett       Date:  2018-07-23       Impact factor: 2.967

4.  Systemic Immune Dyshomeostasis Model and Pathways in Alzheimer's Disease.

Authors:  Puneet Talwar; Suman Kushwaha; Renu Gupta; Rachna Agarwal
Journal:  Front Aging Neurosci       Date:  2019-10-23       Impact factor: 5.750

5.  In vitro 3D phenotypic drug screen identifies celastrol as an effective in vivo inhibitor of polycystic kidney disease.

Authors:  Tijmen H Booij; Wouter N Leonhard; Hester Bange; Kuan Yan; Michiel Fokkelman; Anna J Plugge; Kimberley A M Veraar; Johannes G Dauwerse; Gerard J P van Westen; Bob van de Water; Leo S Price; Dorien J M Peters
Journal:  J Mol Cell Biol       Date:  2020-08-01       Impact factor: 6.216

6.  De novo transcriptome sequencing of Isaria cateniannulata and comparative analysis of gene expression in response to heat and cold stresses.

Authors:  Dingfeng Wang; Liangde Li; Guangyuan Wu; Liette Vasseur; Guang Yang; Pengrong Huang
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.